Marçal Pastor-Anglada mostly deals with Nucleoside, Biochemistry, Nucleoside transporter, Transporter and Equilibrative nucleoside transporter 2. His Nucleoside research integrates issues from Cell culture, Concentrative nucleoside transporter, Hepatocyte, Molecular biology and Equilibrative nucleoside transporter. He combines topics linked to Cell biology with his work on Biochemistry.
The concepts of his Nucleoside transporter study are interwoven with issues in Cancer research, Cytotoxicity and Adenocarcinoma. Marçal Pastor-Anglada works mostly in the field of Transporter, limiting it down to topics relating to Pharmacology and, in certain cases, Efflux. His work investigates the relationship between Equilibrative nucleoside transporter 2 and topics such as Equilibrative nucleoside transporter 1 that intersect with problems in Guanosine.
Marçal Pastor-Anglada focuses on Biochemistry, Nucleoside, Internal medicine, Transporter and Endocrinology. Marçal Pastor-Anglada works mostly in the field of Biochemistry, limiting it down to topics relating to Cell biology and, in certain cases, Adenosine, as a part of the same area of interest. Marçal Pastor-Anglada combines subjects such as Concentrative nucleoside transporter, Nucleoside transporter, Equilibrative nucleoside transporter, Equilibrative nucleoside transporter 2 and Molecular biology with his study of Nucleoside.
His Nucleoside transporter research includes themes of Cancer research and Equilibrative nucleoside transporter 1. His Transporter research focuses on Pharmacology and how it connects with Cisplatin and Chronic lymphocytic leukemia. His research investigates the connection with Endocrinology and areas like Amino acid which intersect with concerns in Enzyme.
Marçal Pastor-Anglada mainly investigates Transporter, Nucleoside, Biochemistry, Pharmacology and Nucleoside transporter. His Transporter research is multidisciplinary, relying on both Confocal microscopy and Flow cytometry. His studies in Nucleoside integrate themes in fields like Nucleotide, Equilibrative nucleoside transporter and Function, Cell biology.
His study in Cell biology is interdisciplinary in nature, drawing from both Membrane transport protein, Adenosine, Cell membrane and Targeted drug delivery. His Biochemistry study combines topics in areas such as Cotransporter and Stereochemistry. His Pharmacology research includes elements of Cell culture, Cisplatin, Oncology, Equilibrative nucleoside transporter 1 and Organic cation transport proteins.
His primary areas of study are Transporter, Nucleoside transporter, Nucleoside, Purinergic signalling and Adenosine. His work carried out in the field of Transporter brings together such families of science as Chronic lymphocytic leukemia, Clinical research, Immune system and Pharmacology. His Nucleoside transporter study is focused on Biochemistry in general.
Many of his studies on Biochemistry involve topics that are commonly interrelated, such as Glucose transporter. His studies deal with areas such as Diabetic nephropathy and Growth factor as well as Adenosine. His research in Internal medicine intersects with topics in Biological activity and Solute carrier family.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Regulatory and molecular aspects of mammalian amino acid transport.
J D McGivan;M Pastor-Anglada.
Biochemical Journal (1994)
Nucleoside Transporter Profiles in Human Pancreatic Cancer Cells Role of hCNT1 in 2′,2′-Difluorodeoxycytidine- Induced Cytotoxicity
José García-Manteiga;Míriam Molina-Arcas;F. Javier Casado;Adela Mazo.
Clinical Cancer Research (2003)
Nucleoside transporter proteins.
Miriam Molina-Arcas;F. Javier Casado;Marcal Pastor-Anglada.
Current Vascular Pharmacology (2009)
Transport of Lamivudine [(-)-β-l-2′,3′-Dideoxy-3′-thiacytidine] and High-Affinity Interaction of Nucleoside Reverse Transcriptase Inhibitors with Human Organic Cation Transporters 1, 2, and 3
Gerard Minuesa;Christopher Volk;Míriam Molina-Arcas;Valentin Gorboulev.
Journal of Pharmacology and Experimental Therapeutics (2009)
Cell entry and export of nucleoside analogues.
Marçal Pastor-Anglada;Pedro Cano-Soldado;Míriam Molina-Arcas;M. Pilar Lostao.
Virus Research (2005)
Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutions
Roland Andersson;Ursula Aho;Bo I. Nilsson;Godefridus J. Peters.
Scandinavian Journal of Gastroenterology (2009)
TRANSPORT AND MODE OF ACTION OF NUCLEOSIDE DERIVATIVES USED IN CHEMICAL AND ANTIVIRAL THERAPIES
M Pastor-Anglada;A Felipe;F J Casado.
Trends in Pharmacological Sciences (1998)
In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta
Rajgopal Govindarajan;Aimee H. Bakken;Kelly L. Hudkins;Yurong Lai;Yurong Lai.
American Journal of Physiology-regulatory Integrative and Comparative Physiology (2007)
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia.
Mı́riam Molina-Arcas;Beatriz Bellosillo;F. Javier Casado;Emili Montserrat.
Nucleoside transporters in chronic lymphocytic leukaemia.
M Pastor-Anglada;M Molina-Arcas;F J Casado;B Bellosillo.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: